Contact Us

Prescribing Information

Please complete the form below and a member of the RINVOQ®▼ team will get back to you.

Please fill in your details below only if you are a registered healthcare professional and would like to request a meeting with an AbbVie representative.

First name*:

Please enter First name

Last name*:

Please enter Last name

E-mail address*:

E-mail address is not valid

Hospital name*:

Please enter Hospital name

Hospital postcode*:

Please enter Hospital postcode

Request a meeting with your local AbbVie representative

I consent to receive AbbVie Ltd communications about its products, services, research, events, programmes and other information, including promotional content, that may be of interest to me using the information I provide. I may withdraw my consent at any time.

Please select one field.

Please refer to the AbbVie privacy notice here for more information on how AbbVie processes your personal data and your data privacy rights.
*Denotes mandatory field

Incorrect. Please try again

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

RINVOQ PRESCRIBING INFORMATION

[Affiliates to insert local adverse events reporting websites]

ALL-RNQG-220167 Date of preparation: November 2022

Adverse events should also be reported to AbbVie on GBPV@abbvie.com

Africa

Asia Pacific

Europe

Middle East

North America

Latin America / Caribbean

South America

test

Immunology

Oncology

Neuroscience

Virology

Eye Care

Trainings

Immunology

Oncology

Neuroscience

Virology

Eye Care

Trainings

Our therapy areas

Our therapy areas

Additional info

Additional info

This website is intended for Healthcare Professionals

This website is intended for Italy Healthcare Professionals